Vibration properties of immune‐oncological drugs
Inhibition of programmed cell death receptor‐1 (PD‐1) and its counterpart ligands PD‐L1 and PD‐L2 pathways by the US‐FDA's approved monoclonal antibodies pembrolizumab and nivolumab has delivered breakthrough therapies against a wide range of cancers, being an important issue for clinical resea...
Gespeichert in:
| Veröffentlicht in: | Journal of Raman spectroscopy 2022-04, Vol.53 (4), p.715-723 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 723 |
|---|---|
| container_issue | 4 |
| container_start_page | 715 |
| container_title | Journal of Raman spectroscopy |
| container_volume | 53 |
| creator | Tavares, Ana Beatriz M.L.A. Albuquerque, Eudenilson L. |
| description | Inhibition of programmed cell death receptor‐1 (PD‐1) and its counterpart ligands PD‐L1 and PD‐L2 pathways by the US‐FDA's approved monoclonal antibodies pembrolizumab and nivolumab has delivered breakthrough therapies against a wide range of cancers, being an important issue for clinical research. Although many structural properties of these drugs have been unveiled, only few studies were focused on their vibrational features. To fill this gap, quantum chemistry calculations are employed to depict the binding energetic modes of these antibody drugs in order to obtain their vibrational properties through a Raman scattering spectroscopy. Detailed interpretation of their harmonic vibrational wavenumbers is also presented, mainly those in the range 2,750 to 3,750 (1,200 to 1,750) cm−1 for the oncological drug pembrolizumab (nivolumab). We believe that our theoretical/computational results may be a new viable technique for improving the cancer disease therapies.
Vibrational spectral investigation of Raman type, based on a quantum chemistry calculation, to identify the normal modes related to the monoclonal anti‐body immune‐oncological pembrolizumab drug. The dashed lines show the most important resonance absorption peaks. |
| doi_str_mv | 10.1002/jrs.6297 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2649741408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2649741408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2547-7db831d62f34c61c58a02a57e40cc1e3db7402677b54037d2ad972d09ee4f6fe3</originalsourceid><addsrcrecordid>eNp10M1KxDAUBeAgCtZR8BEKbtx0vEnz0yxl0FEZEPzbhjRJhwydpiZTZHY-gs_ok9hx3Lq6m497DgehcwxTDECuVjFNOZHiAGUYpCgoY-wQZVAKUQCt-DE6SWkFAFJynCHy5uuoNz50eR9D7-LGu5SHJvfr9dC578-v0JnQhqU3us1tHJbpFB01uk3u7O9O0Ovtzcvsrlg8zu9n14vCEEZFIWxdldhy0pTUcGxYpYFoJhwFY7ArbS0oEC5EzejYzhJtpSAWpHO04Y0rJ-hi_3cs9j64tFGrMMRujFSEUykoplCN6nKvTAwpRdeoPvq1jluFQe0WUeMiarfISIs9_fCt2_7r1MPT86__ASGWYkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2649741408</pqid></control><display><type>article</type><title>Vibration properties of immune‐oncological drugs</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Tavares, Ana Beatriz M.L.A. ; Albuquerque, Eudenilson L.</creator><creatorcontrib>Tavares, Ana Beatriz M.L.A. ; Albuquerque, Eudenilson L.</creatorcontrib><description>Inhibition of programmed cell death receptor‐1 (PD‐1) and its counterpart ligands PD‐L1 and PD‐L2 pathways by the US‐FDA's approved monoclonal antibodies pembrolizumab and nivolumab has delivered breakthrough therapies against a wide range of cancers, being an important issue for clinical research. Although many structural properties of these drugs have been unveiled, only few studies were focused on their vibrational features. To fill this gap, quantum chemistry calculations are employed to depict the binding energetic modes of these antibody drugs in order to obtain their vibrational properties through a Raman scattering spectroscopy. Detailed interpretation of their harmonic vibrational wavenumbers is also presented, mainly those in the range 2,750 to 3,750 (1,200 to 1,750) cm−1 for the oncological drug pembrolizumab (nivolumab). We believe that our theoretical/computational results may be a new viable technique for improving the cancer disease therapies.
Vibrational spectral investigation of Raman type, based on a quantum chemistry calculation, to identify the normal modes related to the monoclonal anti‐body immune‐oncological pembrolizumab drug. The dashed lines show the most important resonance absorption peaks.</description><identifier>ISSN: 0377-0486</identifier><identifier>EISSN: 1097-4555</identifier><identifier>DOI: 10.1002/jrs.6297</identifier><language>eng</language><publisher>Bognor Regis: Wiley Subscription Services, Inc</publisher><subject>Apoptosis ; Cancer ; cancer immunotherapy ; Cell death ; Computer applications ; Drugs ; Immunosuppressive agents ; Monoclonal antibodies ; oncological drugs ; optical absorption ; PD-L1 protein ; Pembrolizumab ; Quantum chemistry ; quantum chemistry simulation ; raman scattering ; Raman spectra ; Spectroscopy ; Vibration</subject><ispartof>Journal of Raman spectroscopy, 2022-04, Vol.53 (4), p.715-723</ispartof><rights>2022 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2547-7db831d62f34c61c58a02a57e40cc1e3db7402677b54037d2ad972d09ee4f6fe3</cites><orcidid>0000-0002-1022-1048</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjrs.6297$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjrs.6297$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Tavares, Ana Beatriz M.L.A.</creatorcontrib><creatorcontrib>Albuquerque, Eudenilson L.</creatorcontrib><title>Vibration properties of immune‐oncological drugs</title><title>Journal of Raman spectroscopy</title><description>Inhibition of programmed cell death receptor‐1 (PD‐1) and its counterpart ligands PD‐L1 and PD‐L2 pathways by the US‐FDA's approved monoclonal antibodies pembrolizumab and nivolumab has delivered breakthrough therapies against a wide range of cancers, being an important issue for clinical research. Although many structural properties of these drugs have been unveiled, only few studies were focused on their vibrational features. To fill this gap, quantum chemistry calculations are employed to depict the binding energetic modes of these antibody drugs in order to obtain their vibrational properties through a Raman scattering spectroscopy. Detailed interpretation of their harmonic vibrational wavenumbers is also presented, mainly those in the range 2,750 to 3,750 (1,200 to 1,750) cm−1 for the oncological drug pembrolizumab (nivolumab). We believe that our theoretical/computational results may be a new viable technique for improving the cancer disease therapies.
Vibrational spectral investigation of Raman type, based on a quantum chemistry calculation, to identify the normal modes related to the monoclonal anti‐body immune‐oncological pembrolizumab drug. The dashed lines show the most important resonance absorption peaks.</description><subject>Apoptosis</subject><subject>Cancer</subject><subject>cancer immunotherapy</subject><subject>Cell death</subject><subject>Computer applications</subject><subject>Drugs</subject><subject>Immunosuppressive agents</subject><subject>Monoclonal antibodies</subject><subject>oncological drugs</subject><subject>optical absorption</subject><subject>PD-L1 protein</subject><subject>Pembrolizumab</subject><subject>Quantum chemistry</subject><subject>quantum chemistry simulation</subject><subject>raman scattering</subject><subject>Raman spectra</subject><subject>Spectroscopy</subject><subject>Vibration</subject><issn>0377-0486</issn><issn>1097-4555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp10M1KxDAUBeAgCtZR8BEKbtx0vEnz0yxl0FEZEPzbhjRJhwydpiZTZHY-gs_ok9hx3Lq6m497DgehcwxTDECuVjFNOZHiAGUYpCgoY-wQZVAKUQCt-DE6SWkFAFJynCHy5uuoNz50eR9D7-LGu5SHJvfr9dC578-v0JnQhqU3us1tHJbpFB01uk3u7O9O0Ovtzcvsrlg8zu9n14vCEEZFIWxdldhy0pTUcGxYpYFoJhwFY7ArbS0oEC5EzejYzhJtpSAWpHO04Y0rJ-hi_3cs9j64tFGrMMRujFSEUykoplCN6nKvTAwpRdeoPvq1jluFQe0WUeMiarfISIs9_fCt2_7r1MPT86__ASGWYkw</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Tavares, Ana Beatriz M.L.A.</creator><creator>Albuquerque, Eudenilson L.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0002-1022-1048</orcidid></search><sort><creationdate>202204</creationdate><title>Vibration properties of immune‐oncological drugs</title><author>Tavares, Ana Beatriz M.L.A. ; Albuquerque, Eudenilson L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2547-7db831d62f34c61c58a02a57e40cc1e3db7402677b54037d2ad972d09ee4f6fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Apoptosis</topic><topic>Cancer</topic><topic>cancer immunotherapy</topic><topic>Cell death</topic><topic>Computer applications</topic><topic>Drugs</topic><topic>Immunosuppressive agents</topic><topic>Monoclonal antibodies</topic><topic>oncological drugs</topic><topic>optical absorption</topic><topic>PD-L1 protein</topic><topic>Pembrolizumab</topic><topic>Quantum chemistry</topic><topic>quantum chemistry simulation</topic><topic>raman scattering</topic><topic>Raman spectra</topic><topic>Spectroscopy</topic><topic>Vibration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tavares, Ana Beatriz M.L.A.</creatorcontrib><creatorcontrib>Albuquerque, Eudenilson L.</creatorcontrib><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of Raman spectroscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tavares, Ana Beatriz M.L.A.</au><au>Albuquerque, Eudenilson L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vibration properties of immune‐oncological drugs</atitle><jtitle>Journal of Raman spectroscopy</jtitle><date>2022-04</date><risdate>2022</risdate><volume>53</volume><issue>4</issue><spage>715</spage><epage>723</epage><pages>715-723</pages><issn>0377-0486</issn><eissn>1097-4555</eissn><abstract>Inhibition of programmed cell death receptor‐1 (PD‐1) and its counterpart ligands PD‐L1 and PD‐L2 pathways by the US‐FDA's approved monoclonal antibodies pembrolizumab and nivolumab has delivered breakthrough therapies against a wide range of cancers, being an important issue for clinical research. Although many structural properties of these drugs have been unveiled, only few studies were focused on their vibrational features. To fill this gap, quantum chemistry calculations are employed to depict the binding energetic modes of these antibody drugs in order to obtain their vibrational properties through a Raman scattering spectroscopy. Detailed interpretation of their harmonic vibrational wavenumbers is also presented, mainly those in the range 2,750 to 3,750 (1,200 to 1,750) cm−1 for the oncological drug pembrolizumab (nivolumab). We believe that our theoretical/computational results may be a new viable technique for improving the cancer disease therapies.
Vibrational spectral investigation of Raman type, based on a quantum chemistry calculation, to identify the normal modes related to the monoclonal anti‐body immune‐oncological pembrolizumab drug. The dashed lines show the most important resonance absorption peaks.</abstract><cop>Bognor Regis</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/jrs.6297</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-1022-1048</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0377-0486 |
| ispartof | Journal of Raman spectroscopy, 2022-04, Vol.53 (4), p.715-723 |
| issn | 0377-0486 1097-4555 |
| language | eng |
| recordid | cdi_proquest_journals_2649741408 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Apoptosis Cancer cancer immunotherapy Cell death Computer applications Drugs Immunosuppressive agents Monoclonal antibodies oncological drugs optical absorption PD-L1 protein Pembrolizumab Quantum chemistry quantum chemistry simulation raman scattering Raman spectra Spectroscopy Vibration |
| title | Vibration properties of immune‐oncological drugs |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T20%3A36%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vibration%20properties%20of%20immune%E2%80%90oncological%20drugs&rft.jtitle=Journal%20of%20Raman%20spectroscopy&rft.au=Tavares,%20Ana%20Beatriz%20M.L.A.&rft.date=2022-04&rft.volume=53&rft.issue=4&rft.spage=715&rft.epage=723&rft.pages=715-723&rft.issn=0377-0486&rft.eissn=1097-4555&rft_id=info:doi/10.1002/jrs.6297&rft_dat=%3Cproquest_cross%3E2649741408%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2649741408&rft_id=info:pmid/&rfr_iscdi=true |